Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging.
Buddingh EP, Slatter M, Becerra JCA, Garcia LA, von Asmuth E, Baris S, de la Calle-Martín O, Chan AY, Chan SB, Chandrakasan S, Chellapandian D, Dara J, Farmand S, Fasth A, Satter LF, Formankova R, Grunebaum E, Keogh SJ, Kiykim A, Kühl JS, Laberko A, Leahy TR, Lindemans C, Martinez C, Martínez-Martínez L, Mitchell WG, Morris E, Oved JH, Polacik M, Rivière JG, Roifman CM, Kilic SS, Sedlacek P, Shah AJ, Vong L, Lankester AC, Albert MH, Neven B, Torgerson T, Leiding J, Schuetz C.
Buddingh EP, et al. Among authors: laberko a.
J Hum Immun. 2025 Sep 1;1(3):10.70962/jhi.20250027. doi: 10.70962/jhi.20250027. Epub 2025 Jul 30.
J Hum Immun. 2025.
PMID: 41142635
Free PMC article.